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If it were not for the ongoing collaboration between vascular surgeons and the medical technology industry, many of
these advanced treatments used every day in vascular interventional surgery would not exist. The flip side of this coin is
that these vital relationships create multiple roles for surgeons and must be appropriately managed.
The dynamic process of innovation, along with factors such as product delivery technique refinement, education,
testing and clinical trials, and product support, all make it necessary for ongoing and close collaboration between
surgeons and the device industry. This unique relationship sometimes leads to the perception of conflicts of interest for
physicians, in part because the competing pressures from the multiple, overlapping roles as clinician/caregiver/
investigator/innovator/customer are significant.
To address this issue, the Advanced Medical Technology Association (AdvaMed), the nation’s largest medical
technology association representing medical device and diagnostics companies, developed a Code of Ethics to guide
medical technology companies in their interactions with health care professionals. First introduced in 1993, the AdvaMed
Code strongly encourages both industry and physicians to commit to openness and high ethical standards in the conduct
of their business interactions.
The AdvaMed Code addresses many of the types of interactions that can occur between companies and health care
professionals, including training, consulting agreements, the provision of demonstration and evaluation units, and
charitable donations. By following the Code, companies send a strong message that treatment decisions must always be
based on the best interest of the patient. ( J Vasc Surg 2011;54:31S-3S.)
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aThe ongoing collaboration between vascular surgeons
and the medical technology industry has made possible
many of the advanced treatments used every day in vascular
and endovascular surgery. Conversely, these vital and com-
plex relationships create multiple and potentially conflict-
ing roles for surgeons and must be appropriately managed.
The dynamic process of innovation, along with factors
such as product delivery technique refinement, education,
testing and clinical trials, and product support, all make it
necessary to preserve ongoing and close collaboration be-
tween surgeons and the device industry. This unique rela-
tionship may lead to the perception, and even reality, of
conflicts of interest for physicians, in part because the
competing pressures from themultiple, overlapping roles as
clinician/caregiver/investigator/innovator/customer are
significant.
Those of us in health care understand how valuable
these relationships are, not only for continued innovation,
but also for patient safety. Therefore, it is essential for the
vascular surgery community and the device industry to
proactively manage the potential for conflicts of interest
while promoting the highest ethical standards.
From AdvaMed.
Competition of interest: none.
Reprint requests: Andrew Van Haute, JD, AdvaMed, 701 Pennsylvania Ave-
nue, Suite 800, Washington DC 20004 (e-mail: avanhaute@advamed.org).
The editors and reviewers of this article have no relevant financial relation-
ships to disclose per the JVS policy that requires reviewers to decline
review of any manuscript for which they may have a competition of
interest.
0741-5214/$36.00p
Copyright © 2011 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2011.05.108NDERSTANDING THE ADVAMED CODE
To address this issue, the Advanced Medical Technol-
gy Association (AdvaMed), the nation’s largest medical
echnology association representing medical device and
iagnostics companies, developed a Code of Ethics to
uide medical technology companies in their interactions
ith health care professionals. First introduced in 1993, the
dvaMed Code strongly encourages both industry and
hysicians to commit to openness and high ethical stan-
ards in the conduct of their business, clinical, and research
nteractions.
The AdvaMed Code has been revised over the years,
ost recently in July of 2009, to address new issues and to
rovide guidance tailored to the unique collaborations in
evice development. Although the revised AdvaMed Code
f Ethics on Interactions with Health Care Professionals, is
irected at medical technology companies, physicians will
lso benefit from the enhanced transparency of properly
ocumented principled relationships described in the Ad-
aMed Code. By adhering to the AdvaMed Code, manu-
acturers are supporting physicians’ obligations to ensure
ach patient is provided with the highest level of care, by
eceiving the treatment option most beneficial to their
ndividual needs.
ECENT UPDATES TO ADVAMED’S CODE
XPAND INTO IMPORTANT NEW AREAS,
UCH AS CODE COMPLIANCE
There is a new Code compliance section, under which a
ist of companies that certify their adoption of the Code are
vailable for public review on AdvaMed’s Web site. Com-
anies are asked to certify that they have implemented an
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ments described in the Office of Inspector General’s guid-
ance in the area. Those that certify adoption of the Code are
also asked to communicate the principles of the Code to
their dealers and distributors with the expectation that they
too will adhere to the Code. In addition, they are required
to provide contact information for either their compliance
department or their anonymous reporting hotlines. This
information is also posted on the association’s Web site and
is intended to facilitate greater communication and ac-
countability in the industry. Finally, because the principles
described in the Code are important for the entire industry,
companies that are not members of AdvaMed are also able
to certify and are listed on the association’s Web site as well.
COMPANY-CONDUCTED TRAINING AND
EDUCATION
The revised Code includes standards to ensure that
company-conducted training and education relating to a
product is provided in an appropriate way and in an appro-
priate setting. Because of the way in which medical tech-
nologies are developed and used, companies have a respon-
sibility to ensure that health care professionals are properly
trained on the safe and effective use of their products.
Often, when dealing with a diffuse population of health
care professionals or with nonportable equipment, these
training and education programs are held in centralized
locations.
THIRD-PARTY CONFERENCES
There is also guidance on the support of third-party
educational conferences. These conferences impart valu-
able information to health care professionals, and compa-
nies may provide grants to reduce conference costs or to
allow attendance by health care professionals in training.
While this support is appropriate, companies should not
control the program content, faculty, methods, or materi-
als. The conference sponsor should independently control
all of those elements. In all cases, this support should
conform to the guidelines of any accrediting body.
ENTERTAINMENT AND GIFT PROHIBITIONS
There is an explicit prohibition in the revised Code on
providing entertainment or recreation to health care pro-
fessionals. Additionally, the changes prohibit gifts of any
type, including all noneducational branded promotional
items, regardless of value. Items given to health care pro-
fessionals must be either educational in nature or intended
to benefit patients. Examples of educational items include
textbooks and anatomical models. An example of patient
benefit items is starter kits. It would be inappropriate to
provide a health care professional with any item that he or
she could use outside a clinical setting, such as an MP3 or
DVD player, even if it were originally loaded with educa-
tional information. bROVISION OF MEALS
A new section consolidates the Code’s guidance on the
rovision of modest, occasional meals to health care pro-
essionals. Meals, if provided, must be secondary to a bona
de educational, scientific, or business discussion, and
hould be provided in an appropriate setting. In addition,
eals should only be provided to health care professionals
ith a bona fide interest in the information being pre-
ented; meals should not be provided to a health care
rofessional’s guests or spouse.
ONSULTING ARRANGEMENTS AND
OYALTIES
Guidance on consulting arrangements with health care
rofessionals has been substantially expanded. Standards in
he revised Code include requiring that consulting agree-
ents are for bona fide services; that there is a legitimate
eed for the services to be provided, that compensation is at
air market value, and above all, that consulting arrange-
ents are not used as an improper inducement for the
ealth care professional’s business. There are also guide-
ines that allow for companies to enter into royalty arrange-
ents with health care professionals in exchange for sub-
tantial contributions that improve medical technologies.
hese payments should not be conditioned on the purchase
r recommendation of the product developed, and compa-
ies are encouraged to consider the propriety of excluding
rom the calculation of the royalty payment any products
urchased by the health care professional or his or her
ractice.
VALUATION AND DEMONSTRATION
RODUCTS
A new section addresses evaluation and demonstration
roducts. This sets forth appropriate parameters under
hich companies may provide products intended to edu-
ate both health care professionals and patients on newer or
mproved medical technologies. Often, a health care pro-
essional will want to evaluate how a particular technology
ill work in practice before making a significant investment
n the technology. A company may provide the item for a
easonable amount of time to allow the health care profes-
ional to make that determination. In addition, companies
ay provide demonstration units, normally not meant for
atient use, to educate health care professionals or to allow
hem to explain procedures to their patients.
BJECTIVE REIMBURSEMENT INFORMATION
An expanded section addresses the provision of objec-
ive reimbursement, coverage, and health economics infor-
ation to health care professionals to improve patient
ccess to medical technologies.
RANTS AND DONATIONS
Revised guidance addresses research and educational
rants and charitable donations. Companies often support
ona fide research and education, as well as legitimate,
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actions with health care professionals. The Code provides
that these grants and donations should not be used improp-
erly to induce business. To achieve this, the Code states that
sales personnel should not control or unduly influence the
decision of whether a particular health care professional will
receive a grant or donation.
Each section is accompanied by a number of frequently
asked questions (FAQs). These questions and answers are
intended to provide practical, real-world guidance on each
section of the Code. While no one can anticipate every
ethical challenge or scenario that may arise, the FAQs will
help medical technology companies create their own poli-
cies and procedures to implement the Code.
PUTTING THE CODE TO WORK
Working with the sales representatives and compliance
professionals within the medical technology companies
with which you interact will help you to fully understand
how the AdvaMed Code impacts your relationship with
these companies.
There are also a number of resources available on
AdvaMed’s Web site available to individuals who wish to Samiliarize themselves with the provisions and content of
he Code. The newest of these tools provides graphical,
asily understood flow charts detailing how a company
hould approach its interactions with health care profes-
ionals under discrete sections of the Code. There are
urrently three of these tools available and AdvaMed will be
dding several more over the course of 2011. Other avail-
ble materials include template training presentations, de-
ailed comparisons between the prior Code and the revised
ode, the ethical codes of other related industries, a useful
rochure succinctly explaining the provisions of the revised
ode, and translations of the Code into a number of
oreign languages. In addition, AdvaMed has developed an
nline, interactive Code training course. These materials
ay be accessed at http://advamed.org/memberportal/
hared/ContentMgt/Templates/OpenDetail.aspx?NRM
DEPublished&NRNODEGUID%7b9234A42C-8E7F-
1E6-9DF4-A2E1D0E57F15%7d&NRORIGINALURL
2fMemberPortal%2fAbout%2fcode%2fdefault.htm%3fWBC
ODE%3dPresentationUnpublished&NRCACHEHINT
oModi#AdvaMed%20Code%20of%20Ethicsubmitted Mar 1, 2011; accepted May 7, 2011.
